Landscapes / Companies
DualityBio Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
9
in active trials · 10 in all
Trials
11 active
12 since 2021
Drugs9
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Aug 2027Phase 1/2 trial completes | |||
| Next date | Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | HER2-positive Advanced Solid Tumor, Metastatic Breast Cancer and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Feb 2027Phase 1/2 trial completes | |||
| Next date | Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Adult | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Jun 2027Phase 1/2 trial completes | |||
| Next date | 30 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus | ||||
| Open drug page | |||||
— |
Phase 2 | 13 Aug 2027Phase 1/2 trial completes | |||
| Next date | 13 Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2027Phase 1/2 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
BioNTech |
Phase 1/2 | Dec 2027Phase 1/2 trial completes | ||
| Next date | Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2028Phase 1/2 trial completes | |||
| Next date | Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Gastrointestinal Cancer | ||||
| Open drug page | |||||
— |
Phase 2 | 30 Jun 2030Phase 2 trial completes | |||
| Next date | 30 Jun 2030 · Phase 2 trial completes | ||||
| Also tested for | Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2028Phase 1 trial completes | |||
| Next date | Jun 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced/Metastatic Solid Tumors | ||||
| Open drug page | |||||
About
- No active trial
- DB-1202
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021